Severe Lactic Acidosis in Decompensated Cirrhosis Despite Nondiagnostic Imaging Authors: Nakul Ganju, Chibuzor Victor Nwachukwu, Juan Santiago‐Gonzalez, Shaharyar Naeem, Nicholas Azinge, Adeyinka O Laiyemo Published: 2026 ABSTRACT ABSTRACTLactic acidosis is a strong predictor of mortality in cirrhosis, reflecting both impaired hepatic clearance and systemic tissue hypoxia. We describe a 38‐year‐old man with decompensated alcohol‐associated cirrhosis who developed severe lactic acidosis despite stable hemodynamics and initially nondiagnostic vascular imaging. Repeat computed tomography demonstrated rectal wall thickening with mesenteric fat stranding, concerning for ischemic injury in the setting of a low‐flow state. The patient subsequently experienced pulseless electrical activity arrest and died. This case highlights the prognostic significance of rising lactate in cirrhosis and underscores that severe hyperlactatemia should prompt urgent evaluation for occult hypoperfusion even when early imaging is nondiagnostic.Keywords: cirrhosis, hypoperfusion, imaging, lactic acidosis, prognostication Introduction Lactic acidosis is a powerful prognostic marker in patients with cirrhosis, reflecting impaired hepatic clearance as well as increased lactate production during systemic stress. Even modest elevations are associated with adverse outcomes, and rising lactate levels correlate strongly with short‐term mortality independent of overt shock. Prognostic models incorporating lactate, such as Model for End‐Stage Liver Disease (MELD)‐Lactate, outperform traditional scoring systems for short‐term risk stratification in hospitalized patients with cirrhosis, particularly during acute decompensation or infection [1, 2, 3, 4]. Guidelines from the American Association for the Study of Liver Diseases and the American Gastroenterological Association emphasize that rising lactate in unstable cirrhotic patients should be interpreted as tissue hypoxia until proven otherwise and should prompt urgent evaluation [1, 5]. Cirrhotic patients are predisposed to low‐flow states due to portal hypertension, systemic vasodilation, microvascular dysfunction, and impaired autoregulation, which may result in occult hypoperfusion even when systemic blood pressure appears preserved [5, 6]. Clinical manifestations may be subtle, and early imaging may be nondiagnostic. We present a case of severe lactic acidosis in decompensated cirrhosis with initially nondiagnostic imaging, illustrating the prognostic importance of hyperlactatemia as a marker of global hypoperfusion rather than a purely metabolic abnormality. Case Presentation A 38‐year‐old Spanish‐speaking man with decompensated alcohol‐associated cirrhosis (Model for End‐Stage Liver Disease–Sodium [MELD‐Na] score 23) complicated by portal hypertension and esophageal varices presented after a syncopal episode at a rehabilitation facility. He had been diagnosed with compensated cirrhosis approximately 2 years prior to this admission, with clinical decompensation occurring roughly 6 months before the index hospitalization. He reported 1 week of melena, generalized abdominal pain, and progressive lightheadedness, followed by transient confusion and chest discomfort. His medical history included congestive heart failure with reduced ejection fraction (40%–45%), macrocytic anemia, severe thrombocytopenia, hypertension, and remote lobectomy for lung abscess. He reported long‐standing heavy alcohol use beginning in adolescence, with abstinence for 8 months prior to presentation. His body mass index (BMI) was 24.3 kg/m2. No prior genetic workup for hereditary liver disease (e.g., hemochromatosis, alpha‐1 antitrypsin deficiency, or PNPLA3 I148M genotyping) had been performed or documented in available records. Home medications included carvedilol, furosemide, spironolactone, lactulose, escitalopram, pantoprazole, ciprofloxacin for spontaneous bacterial peritonitis prophylaxis, thiamine, folic acid, and cyanocobalamin. On admission, he was alert but fatigued. Vital signs were stable with blood pressure 122/91 mmHg, heart rate 69 beats/min, temperature 98.4°F, and respiratory rate 18 breaths/min. Abdominal examination was soft and nondistended without guarding or rebound. Laboratory evaluation demonstrated albumin 2.9 g/dL (reference range: 3.5–5.0 g/dL), total bilirubin 7.0 mg/dL (reference: 0.2–1.2 mg/dL), AST 69 U/L (reference: 10–40 U/L), ALT 38 U/L (reference: 7–56 U/L), alkaline phosphatase 186 U/L (reference: 44–147 U/L), INR 1.93 (reference: 0.8–1.1), macrocytic anemia (hemoglobin 8.4 g/dL [reference: 13.5–17.5 g/dL], MCV 104 fL [reference: 80–100 fL]), and platelet count 26 × 103/μL (reference: 150–400 × 103/μL). Differential Diagnosis, Investigations and Treatment Initial differential considerations included upper gastrointestinal bleeding, infection‐related hypoperfusion, cardiogenic low‐output state, and ischemic injury related to systemic hypoperfusion. A computed tomography (CT) scan of the abdomen and pelvis obtained prior to admission demonstrated cirrhosis with portal hypertension, splenomegaly, varices, gallbladder wall thickening, trace ascites, and a small presacral fluid collection. During hospitalization, the patient developed acute worsening abdominal pain with multiple urgent bowel movements. Repeat laboratory testing revealed worsening hepatocellular injury (AST 205 U/L, ALT 76 U/L), persistent hyperbilirubinemia (7.2 mg/dL), elevated B‐type natriuretic peptide (1218 pg/mL), and rising serum lactate to 7.3 mmol/L. Despite preserved blood pressure and oxygenation, lactate levels remained elevated above 6 mmol/L over the following 24 h. Right upper quadrant ultrasound demonstrated absent portal vein flow, initially raising concern for thrombosis (Figure 1). However, CT angiography demonstrated patent mesenteric and portal vessels without evidence of occlusion (Figure 2), consistent with a functional rather than occlusive etiology; in cirrhotic patients, absent Doppler signal may reflect markedly reduced flow velocity rather than true thrombosis [7]. Supportive management was continued. Right upper quadrant ultrasound sequence demonstrating hepatobiliary and vascular findings. (A) Grayscale image showing cirrhotic hepatic texture and common bile duct (CBD). (B) Color doppler demonstrating preserved vascular signals adjacent to the CBD. (C) Color doppler image of the portal vein showing absent flow, initially concerning for thrombosis. Contrast‐enhanced CT angiography of the abdomen and pelvis demonstrating patent mesenteric vessels and portal venous system without evidence of thrombosis. Given ongoing abdominal pain and severe hyperlactatemia, repeat non‐contrast CT imaging was obtained, demonstrating asymmetric rectal wall thickening with mesenteric fat stranding, findings concerning for ischemic injury in the setting of a low‐flow state (Figure 3). Axial non‐contrast CT demonstrating asymmetric rectal wall thickening and adjacent mesenteric fat stranding, findings consistent with ischemic injury. Conclusion and Results (Outcome and Follow‐Up) Shortly after repeat imaging, the patient developed pulseless electrical activity arrest. Despite 35 min of advanced cardiac life support, return of spontaneous circulation was not achieved, and the patient was pronounced deceased. No autopsy was performed. Discussion This case illustrates the prognostic significance of severe lactic acidosis in patients with decompensated cirrhosis and shares important features with previously described cases of fatal hyperlactatemia in end‐stage liver disease. Impaired hepatic clearance combined with increased lactate production during systemic stress alters lactate metabolism in this population, making hyperlactatemia an independent predictor of mortality even in the absence of overt hypotension [2, 3, 4]. In the landmark multinational study by Drolz et al., lactate levels above 4 mmol/L were independently associated with 28‐day mortality in critically ill cirrhotic patients, and non‐clearing lactate over 12 h was among the strongest predictors of death [2]. Similarly, Mahmud et al. demonstrated in a national cohort that MELD‐Lactate outperformed MELD‐Na for predicting in‐hospital mortality, underscoring the incremental value of lactate beyond standard prognostic scores [4, 8]. Our patient's peak lactate of 7.3 mmol/L, combined with failure to clear over 24 h, places him in the highest‐risk category described in these series. Rising or non‐clearing lactate signals ongoing tissue hypoxia rather than isolated metabolic dysfunction. Guidelines from the American Association for the Study of Liver Diseases, American Gastroenterological Association, and American College of Gastroenterology emphasize that rising lactate in unstable cirrhotic patients should be treated as evidence of tissue hypoxia until proven otherwise [1, 5]. Cirrhosis predisposes patients to low‐flow states through systemic vasodilation, microvascular dysfunction, impaired cardiac reserve, and altered autoregulation [5, 6]. As a result, significant hypoperfusion may occur despite preserved systemic blood pressure. Radiologic evaluation may be limited in this context. While CT angiography is effective for identifying occlusive vascular pathology, it may fail to detect nonocclusive mesenteric ischemia or low‐flow states. When imaging is nondiagnostic, a systematic multimodal approach is warranted. Clinically, serial lactate measurements every 4–6 h provide the most reliable indicator of ongoing tissue ischemia; failure of lactate to decrease by 10% over 2 h has been associated with significantly worse outcomes in critically ill cirrhotic patients [2]. Hemodynamically, point‐of‐care echocardiography can rapidly assess left ventricular function, volume status, and inferior vena cava collapsibility to identify a low‐output state even when systemic blood pressure appears preserved. Rising creatinine, worsening transaminases, and elevated BNP—all present in our patient—serve as laboratory surrogates of multiorgan hypoperfusion and should heighten clinical suspicion. Intestinal fatty acid binding protein (I‐FABP) is an emerging biomarker of early mesenteric ischemia that may be detectable before radiologic changes appear [9]. In this case, reliance on initial CT angiography without integration of serial lactate trends and hemodynamic assessment delayed recognition of a fatal low‐flow process. The subsequent identification of ischemic changes on repeat imaging underscored that such findings reflected advanced systemic hypoperfusion rather than isolated bowel pathology. Author Contributions Nakul Ganju: conceptualization, writing – original draft. Chibuzor Victor Nwachukwu: conceptualization, writing – original draft. Juan Santiago‐Gonzalez: conceptualization, writing – original draft, writing – review and editing. Shaharyar Naeem: conceptualization, writing – original draft. Nicholas Azinge: conceptualization. Adeyinka O. Laiyemo: conceptualization, supervision, validation, writing – review and editing. Funding The authors have nothing to report. Disclosure No artificial intelligence tools or technologies were utilized during the preparation of this manuscript. Consent Written informed consent for publication of this case report and accompanying images was obtained from the patient's legally authorized representative. Conflicts of Interest The authors declare no conflicts of interest. Acknowledgments The authors thank the medical, nursing, and ancillary staff involved in the care of this patient. Data Availability Statement Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study. References Associated Data Data Availability Statement Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.